HAMP and sickle cell disease: Previous studies have indicated that specific genetic variations in the HAMP promoter region can lead to diminished hepcidin expression, potentially leading to elevated serum iron levels [28–30] This study aimed to determine the genotypic variants in the hepcidin gene promoter (rs10421768) and the phenotypic levels of hepcidin protein in sickle cell anaemia patients.